Literature DB >> 23699783

Autoantibodies in sporadic Creutzfeldt-Jakob disease.

Heather Angus-Leppan1, Peter Rudge, Simon Mead, John Collinge, Angela Vincent.   

Abstract

IMPORTANCE: The diagnosis of autoimmune and neurodegenerative conditions can be unclear. Treatments such as removing the associated tumor, if present, and immunosuppression can halt or often reverse the progression of autoimmune conditions, but there is no curative treatment for neurodegenerative conditions. The presence of autoantibodies can sometimes be misleading. This report illustrates potential difficulties in differentiating autoimmune encephalopathies from sporadic Creutzfeldt-Jakob disease. OBSERVATIONS: In a clinical follow-up of an older man with rapidly evolving encephalopathy at a neuroscience center, unsuccessful treatment with immunosuppression based on the incorrect presumptive diagnosis of Morvan syndrome was followed by the correct histological diagnosis of sporadic Creutzfeldt-Jakob disease. CONCLUSIONS AND RELEVANCE: Autoimmune encephalopathies raise important treatment options and potential for recovery. However, since neuronal antibodies may be positive in prion disease, interpretation can be complex and must be rooted in the clinical picture.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23699783     DOI: 10.1001/jamaneurol.2013.2077

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  18 in total

Review 1.  Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia.

Authors:  Ed Needham; Michael S Zandi
Journal:  J Neurol       Date:  2014-09-03       Impact factor: 4.849

2.  Presence of voltage-gated potassium channel complex antibody in a case of genetic prion disease.

Authors:  Adham Jammoul; Richard J Lederman; Jinny Tavee; Yuebing Li
Journal:  BMJ Case Rep       Date:  2014-06-05

3.  Peripheral nervous system hyperexcitability in VV2 sporadic Creutzfeldt-Jakob disease.

Authors:  Charlene J Ong; Muhammad Al-Lozi; Patrick J Cimino; Robert Bucelli
Journal:  Neurol Clin Pract       Date:  2015-08

4.  An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre.

Authors:  S Huda; S H Wong; P Pettingill; D O'Connell; A Vincent; M Steiger
Journal:  J Neurol       Date:  2014-11-27       Impact factor: 4.849

5.  Heidenhain variant sporadic Creutzfeldt-Jakob disease diagnosed as an autoimmune encephalitis due to a false-positive GAD autoantibody.

Authors:  Nicolás Urriola; Kavie Soosapilla; Geoffrey Herkes; Joseph Nogajski
Journal:  BMJ Case Rep       Date:  2019-05-06

6.  Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.

Authors:  Helena Ariño; Thais Armangué; Mar Petit-Pedrol; Lidia Sabater; Eugenia Martinez-Hernandez; Makoto Hara; Eric Lancaster; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2016-07-27       Impact factor: 9.910

7.  Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease.

Authors:  Oriol Grau-Rivera; Raquel Sánchez-Valle; Albert Saiz; José Luis Molinuevo; Reyes Bernabé; Elvira Munteis; Francesc Pujadas; Antoni Salvador; Júlia Saura; Antonio Ugarte; Maarten Titulaer; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

8.  Gerstmann-Straüssler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies.

Authors:  Matthew Jones; Sola Odunsi; Daniel du Plessis; Angela Vincent; Matthew Bishop; Mark W Head; James W Ironside; David Gow
Journal:  Neurology       Date:  2014-05-09       Impact factor: 9.910

Review 9.  Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.

Authors:  James Varley; Angela Vincent; Sarosh R Irani
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

10.  Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease.

Authors:  Meghan Rossi; Simon Mead; John Collinge; Peter Rudge; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-09-22       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.